Regarding the total abdominal fat area, within-group analysis showed no significant difference in the SKO-001 group, but a decreasing trend was observed.
← all excerpts
A 12-Week, Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial for the Evaluation of the Efficacy and Safety of <i>Lactiplantibacillus plantarum</i> SKO-001 in Reducing Body Fat.
1
—
—